The mobile cancer screening devices market size has grown rapidly in recent years. It will grow from $4.88 billion in 2025 to $5.54 billion in 2026 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to increasing global cancer prevalence rates, growth in government cancer awareness initiatives, rising demand for early diagnosis programs, expansion of healthcare access in underserved regions, increasing healthcare infrastructure investments.
The mobile cancer screening devices market size is expected to see rapid growth in the next few years. It will grow to $9.05 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to increasing investment in portable diagnostic technologies, rising adoption of AI based screening platforms, growing demand for decentralized healthcare services, expansion of preventive healthcare programs, increasing development of advanced molecular diagnostic solutions. Major trends in the forecast period include increasing adoption of portable cancer screening solutions, rising demand for early cancer detection technologies, growing deployment of community based screening programs, increasing focus on point of care diagnostic capabilities, expanding use of remote healthcare screening services.
The increasing incidence of cancer is expected to propel the growth of the mobile cancer screening devices market going forward. Cancer incidence refers to the number of new cancer cases diagnosed within a specific population during a certain period. The rising incidence of cancer is driven by an aging population, as advancing age leads to the accumulation of genetic mutations and a gradual decline in the body’s ability to repair damaged cells, thereby increasing cancer risk over time. Mobile cancer screening devices support cancer detection by enabling early, accessible, and on-the-spot diagnosis, which improves timely treatment initiation and significantly enhances the chances of better patient outcomes. For instance, in January 2026, according to the Centers for Disease Control and Prevention, a US-based government agency, 1,851,238 new cancer cases were recorded in 2022, and 613,349 deaths due to cancer occurred in 2023. Therefore, the increasing incidence of cancer is driving the growth of the mobile cancer screening devices market.
Major companies operating in the mobile cancer screening devices market are focusing on developing innovative solutions such as AI-enabled mobile diagnostic screening units to enable early and accurate cancer detection, improve diagnostic access in remote areas, and enhance overall screening efficiency. AI-enabled mobile diagnostic screening units are portable healthcare systems integrated with artificial intelligence tools that analyze medical data on-site to enable fast, accurate, and early disease screening in remote or underserved regions. For instance, in February 2026, Kamala Nehru Memorial Hospital, a India-based not-for-profit multi-specialty institution, in collaboration with Lenek Technologies, a India-based health-tech startup, launched a project to develop a portable AI-enabled device for early lung cancer detection. The initiative aims to integrate artificial intelligence with clinical diagnostics to improve the speed and accuracy of lung cancer screening, particularly in early-stage cases, while also expanding access to advanced diagnostic capabilities in remote and resource-limited healthcare settings.
In March 2026, Lord’s Mark Industries Limited, an India-based healthcare and medical technology company, partnered with the Centre for Materials for Electronic Technology (CMET), an India-based government research organization specializing in electronic materials and advanced technology development, to develop an AI-based breast cancer detection device. This partnership aims to advance early and accessible breast cancer screening by combining Lord’s Mark Industries Limited’s expertise in healthcare technology development and commercialization with CMET’s capabilities in advanced electronic materials research and sensor technologies. The collaboration focuses on creating a portable, radiation-free screening system that uses AI-driven thermal imaging to detect early abnormalities.
Major companies operating in the mobile cancer screening devices market are Siemens Healthineers AG; GE HealthCare Technologies Inc.; Philips Healthcare; FUJIFILM Holdings Corporation; Hologic Inc.; Canon Medical Systems Corporation; Shimadzu Corporation; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Konica Minolta Inc.; Samsung Medison Co. Ltd.; SonoSite (Fujifilm); Carestream Health Inc.; Neusoft Medical Systems; Esaote S.p.A.; Samsung NeuroLogica; Butterfly Network Inc.; Trivitron Healthcare Pvt. Ltd.; Planmed Oy; BPL Medical Technologies Private Limited; UE LifeSciences Inc.; Niramai Health Analytix Private Limited; Forward Science LLC.
North America was the largest region in the mobile cancer screening devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mobile cancer screening devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mobile cancer screening devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The mobile cancer screening devices market consists of revenues earned by entities by providing services such as on-site cancer screening services, mobile diagnostic imaging services, early detection and screening program management services, tele-diagnostic and remote reporting services, and equipment leasing and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The mobile cancer screening devices market also includes sales of sample collection kits, liquid biopsy assay kits, molecular diagnostic reagents, and sample preservation and transport media kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The mobile cancer screening devices market research report is one of a series of new reports that provides mobile cancer screening devices market statistics, including mobile cancer screening devices industry global market size, regional shares, competitors with a mobile cancer screening devices market share, detailed mobile cancer screening devices market segments, market trends and opportunities, and any further data you may need to thrive in the mobile cancer screening devices industry. This mobile cancer screening devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
The mobile cancer screening devices market size is expected to see rapid growth in the next few years. It will grow to $9.05 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to increasing investment in portable diagnostic technologies, rising adoption of AI based screening platforms, growing demand for decentralized healthcare services, expansion of preventive healthcare programs, increasing development of advanced molecular diagnostic solutions. Major trends in the forecast period include increasing adoption of portable cancer screening solutions, rising demand for early cancer detection technologies, growing deployment of community based screening programs, increasing focus on point of care diagnostic capabilities, expanding use of remote healthcare screening services.
The increasing incidence of cancer is expected to propel the growth of the mobile cancer screening devices market going forward. Cancer incidence refers to the number of new cancer cases diagnosed within a specific population during a certain period. The rising incidence of cancer is driven by an aging population, as advancing age leads to the accumulation of genetic mutations and a gradual decline in the body’s ability to repair damaged cells, thereby increasing cancer risk over time. Mobile cancer screening devices support cancer detection by enabling early, accessible, and on-the-spot diagnosis, which improves timely treatment initiation and significantly enhances the chances of better patient outcomes. For instance, in January 2026, according to the Centers for Disease Control and Prevention, a US-based government agency, 1,851,238 new cancer cases were recorded in 2022, and 613,349 deaths due to cancer occurred in 2023. Therefore, the increasing incidence of cancer is driving the growth of the mobile cancer screening devices market.
Major companies operating in the mobile cancer screening devices market are focusing on developing innovative solutions such as AI-enabled mobile diagnostic screening units to enable early and accurate cancer detection, improve diagnostic access in remote areas, and enhance overall screening efficiency. AI-enabled mobile diagnostic screening units are portable healthcare systems integrated with artificial intelligence tools that analyze medical data on-site to enable fast, accurate, and early disease screening in remote or underserved regions. For instance, in February 2026, Kamala Nehru Memorial Hospital, a India-based not-for-profit multi-specialty institution, in collaboration with Lenek Technologies, a India-based health-tech startup, launched a project to develop a portable AI-enabled device for early lung cancer detection. The initiative aims to integrate artificial intelligence with clinical diagnostics to improve the speed and accuracy of lung cancer screening, particularly in early-stage cases, while also expanding access to advanced diagnostic capabilities in remote and resource-limited healthcare settings.
In March 2026, Lord’s Mark Industries Limited, an India-based healthcare and medical technology company, partnered with the Centre for Materials for Electronic Technology (CMET), an India-based government research organization specializing in electronic materials and advanced technology development, to develop an AI-based breast cancer detection device. This partnership aims to advance early and accessible breast cancer screening by combining Lord’s Mark Industries Limited’s expertise in healthcare technology development and commercialization with CMET’s capabilities in advanced electronic materials research and sensor technologies. The collaboration focuses on creating a portable, radiation-free screening system that uses AI-driven thermal imaging to detect early abnormalities.
Major companies operating in the mobile cancer screening devices market are Siemens Healthineers AG; GE HealthCare Technologies Inc.; Philips Healthcare; FUJIFILM Holdings Corporation; Hologic Inc.; Canon Medical Systems Corporation; Shimadzu Corporation; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Konica Minolta Inc.; Samsung Medison Co. Ltd.; SonoSite (Fujifilm); Carestream Health Inc.; Neusoft Medical Systems; Esaote S.p.A.; Samsung NeuroLogica; Butterfly Network Inc.; Trivitron Healthcare Pvt. Ltd.; Planmed Oy; BPL Medical Technologies Private Limited; UE LifeSciences Inc.; Niramai Health Analytix Private Limited; Forward Science LLC.
North America was the largest region in the mobile cancer screening devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mobile cancer screening devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mobile cancer screening devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The mobile cancer screening devices market consists of revenues earned by entities by providing services such as on-site cancer screening services, mobile diagnostic imaging services, early detection and screening program management services, tele-diagnostic and remote reporting services, and equipment leasing and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The mobile cancer screening devices market also includes sales of sample collection kits, liquid biopsy assay kits, molecular diagnostic reagents, and sample preservation and transport media kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The mobile cancer screening devices market research report is one of a series of new reports that provides mobile cancer screening devices market statistics, including mobile cancer screening devices industry global market size, regional shares, competitors with a mobile cancer screening devices market share, detailed mobile cancer screening devices market segments, market trends and opportunities, and any further data you may need to thrive in the mobile cancer screening devices industry. This mobile cancer screening devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Mobile Cancer Screening Devices Market Characteristics
3. Mobile Cancer Screening Devices Market Supply Chain Analysis
4. Global Mobile Cancer Screening Devices Market Trends And Strategies
5. Mobile Cancer Screening Devices Market Analysis Of End Use Industries
7. Global Mobile Cancer Screening Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
8. Global Mobile Cancer Screening Devices Total Addressable Market (TAM) Analysis for the Market
9. Mobile Cancer Screening Devices Market Segmentation
10. Mobile Cancer Screening Devices Market Regional And Country Analysis
11. Asia-Pacific Mobile Cancer Screening Devices Market
12. China Mobile Cancer Screening Devices Market
13. India Mobile Cancer Screening Devices Market
14. Japan Mobile Cancer Screening Devices Market
15. Australia Mobile Cancer Screening Devices Market
16. Indonesia Mobile Cancer Screening Devices Market
17. South Korea Mobile Cancer Screening Devices Market
18. Taiwan Mobile Cancer Screening Devices Market
19. South East Asia Mobile Cancer Screening Devices Market
20. Western Europe Mobile Cancer Screening Devices Market
21. UK Mobile Cancer Screening Devices Market
22. Germany Mobile Cancer Screening Devices Market
23. France Mobile Cancer Screening Devices Market
24. Italy Mobile Cancer Screening Devices Market
25. Spain Mobile Cancer Screening Devices Market
26. Eastern Europe Mobile Cancer Screening Devices Market
27. Russia Mobile Cancer Screening Devices Market
28. North America Mobile Cancer Screening Devices Market
29. USA Mobile Cancer Screening Devices Market
30. Canada Mobile Cancer Screening Devices Market
31. South America Mobile Cancer Screening Devices Market
32. Brazil Mobile Cancer Screening Devices Market
33. Middle East Mobile Cancer Screening Devices Market
34. Africa Mobile Cancer Screening Devices Market
36. Mobile Cancer Screening Devices Market Competitive Landscape And Company Profiles
37. Mobile Cancer Screening Devices Market Other Major And Innovative Companies
41. Mobile Cancer Screening Devices Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Mobile Cancer Screening Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses mobile cancer screening devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for mobile cancer screening devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mobile cancer screening devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Imaging Devices; Diagnostic And Detection Devices; Endoscopy Devices; Biopsy Devices2) By Cancer Type: Breast Cancer; Lung Cancer; Colorectal Cancer; Cervical Cancer; Prostate Cancer; Skin Cancer
3) By Technology: Ultrasound Technology; Computed Tomography Technology; Magnetic Resonance Imaging Technology; Molecular Diagnostics Technology; Artificial Intelligence Based Screening Technology
4) By End User: Hospitals; Diagnostic Centers; Mobile Screening Clinics; Ambulatory Care Centers; Community Healthcare Programs
Subsegments:
1) By Imaging Devices: Portable Mammography Systems; Mobile Computed Tomography Scanners; Portable Magnetic Resonance Imaging Systems; Handheld Ultrasound Devices; Mobile Positron Emission Tomography Systems2) By Diagnostic And Detection Devices: Liquid Biopsy Devices; Molecular Diagnostic Devices; Biomarker Detection Devices; Point Of Care Diagnostic Analyzers; Cancer Screening Test Kits
3) By Endoscopy Devices: Portable Gastrointestinal Endoscopy Devices; Mobile Bronchoscopy Systems; Capsule Endoscopy Devices; Flexible Endoscopy Systems; Wireless Endoscopy Devices
4) By Biopsy Devices: Needle Biopsy Devices; Vacuum Assisted Biopsy Devices; Image Guided Biopsy Systems; Core Needle Biopsy Devices; Fine Needle Aspiration Devices
Companies Mentioned: Siemens Healthineers AG; GE HealthCare Technologies Inc.; Philips Healthcare; FUJIFILM Holdings Corporation; Hologic Inc.; Canon Medical Systems Corporation; Shimadzu Corporation; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Konica Minolta Inc.; Samsung Medison Co. Ltd.; SonoSite (Fujifilm); Carestream Health Inc.; Neusoft Medical Systems; Esaote S.p.A.; Samsung NeuroLogica; Butterfly Network Inc.; Trivitron Healthcare Pvt. Ltd.; Planmed Oy; BPL Medical Technologies Private Limited; UE LifeSciences Inc.; Niramai Health Analytix Private Limited; Forward Science LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
- Siemens Healthineers AG
- GE HealthCare Technologies Inc.
- Philips Healthcare
- FUJIFILM Holdings Corporation
- Hologic Inc.
- Canon Medical Systems Corporation
- Shimadzu Corporation
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Konica Minolta Inc.
- Samsung Medison Co. Ltd.
- SonoSite (Fujifilm)
- Carestream Health Inc.
- Neusoft Medical Systems
- Esaote S.p.A.
- Samsung NeuroLogica
- Butterfly Network Inc.
- Trivitron Healthcare Pvt. Ltd.
- Planmed Oy
- BPL Medical Technologies Private Limited
- UE LifeSciences Inc.
- Niramai Health Analytix Private Limited
- Forward Science LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | August 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.54 Billion |
| Forecasted Market Value ( USD | $ 9.05 Billion |
| Compound Annual Growth Rate | 13.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
